Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

20.0%

3 terminated out of 15 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

33%

5 trials in Phase 3/4

Results Transparency

67%

6 of 9 completed with results

Key Signals

6 with results75% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (3)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (4)

Trial Status

Completed9
Terminated3
Unknown2
Active Not Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
Showing all 15 trials

Research Network

Activity Timeline